Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Clonal Evolution of Therapy-Related Myeloid Neoplasm Analyzed Sequentially By Targeted Deep Sequencing Using Bone Marrow Cells

Katagiri Seiichiro, MD PhD, Kenko Azuma, PhD, Yuu Saitoh, MD, Seiichiro Yoshizawa, MD PhD, Daigo Akahane, MD PhD, Hiroaki Fujimoto, MD, Yoshikazu Ito, MD PhD, Tomohiro Umezu, PhD, Junko.H Ohyashiki, MD PhD, Kazuma Ohyashiki, MD PhD

Blood (2018) 132 (Supplement 1): 5525.

https://doi.org/10.1182/blood-2018-99-113317

Published: 2018

Journal Articles

BCL2L11 ( BIM ) Deletion Polymorphism Is Associated with Molecular Relapse after ABL Tyrosine Kinase Inhibitor Discontinuation in Patients with Chronic Myeloid Leukemia with Complete Molecular Response

Seiichiro Katagiri, MD PhD, Tetsuzo Tauchi, MD PhD, Yuu Saito, MD, Tamiko Sugro, MD, Michiyo Asano, MD, Seiichiro Yoshizawa, MD PhD, Juri Sakuta, MD PhD, Daigo Akahane, MD PhD, Yuko Tanaka, MD PhD, Nahoko Furuya, MD PhD, Keiko Ando, MD PhD, Hiroaki Fujimoto, MD, Seiichi Okabe, MD PhD, Moritaka Gotoh, MD PhD, Yoshikazu Ito, MD PhD, Tomohiro Umezu, PhD, Junko H Ohyashiki, MD PhD, Kazuma Ohyashiki, MD PhD

Blood (2014) 124 (21): 1797.

https://doi.org/10.1182/blood.V124.21.1797.1797

Published: 2014

Journal Articles

Utility of Percutaneous Image-Guided Biopsy to Diagnose Intraabdominal Lymphoma with Coaxial Core Needles,

Ikuo Shimizu, MD, Keijiro Sato, MD, Yuko Fujikawa, MD, Toshimitsu Ueki, MD, Daigo Akahane, MD, PhD, Masahiko Sumi, MD, PhD, Mayumi Ueno, MD, PhD, Naoaki Ichikawa, MD, PhD, Hikaru Kobayashi, MD, PhD, Yoichi Okazaki, MD, PhD

Blood (2011) 118 (21): 4214.

https://doi.org/10.1182/blood.V118.21.4214.4214

Published: 2011

Journal Articles

Combined Effects of Novel Heat Shock Protein 90 Inhibitor NVP-AUY922 and Nilotinib against Mutant Forms of BCR-ABL

Tetsuzo Tauchi, MD, PhD, Daigo Akahane, MD, Seiichi Okabe, MD, PhD, Eishi Ashihara, MD, Shinya Kimura, MD, PhD, Taira Maekawa, MD, PhD, Kazuma Ohyashiki, MD, PhD

Blood (2008) 112 (11): 724.

https://doi.org/10.1182/blood.V112.11.724.724

Published: 2008

Journal Articles

Combined Effects of a Pan-Aurora Kinase Inhibitor MK-0457 and Dasatinib Against T315I Mutant Form of BCR-ABL: In Vitro and In Vivo Studies.

Tetsuzo Tauchi, MD, Daigo Akahane, MD, Kousuke Nunoda, MD, Seiichi Okabe, MD, John Pollard, PhD, Kazuma Ohyashiki, MD

Blood (2007) 110 (11): 805.

https://doi.org/10.1182/blood.V110.11.805.805

Published: 2007

Journal Articles

Activity of a Novel Aurora Kinase Inhibitor, VE-465, Against T315I Mutant Form of BCR-ABL: In Vitro and In Vivo Studies.

Tetsuzo Tauchi, MD, Daigo Akahane, MD, Kosuke Nunoda, MD, Seiichi Okabe, MD, Kazuma Ohyashiki, MD

Blood (2006) 108 (11): 1358.

https://doi.org/10.1182/blood.V108.11.1358.1358

Published: 2006

Journal Articles

Identification and Functional Significance of Genes Regulated by Structurally Different ABL Kinase Inhibitors.

Kousuke Nunoda, MD, Tetsuzo Tauchi, MD, Tomoiku Takaku, MD, Masahiko Sumi, MD, Seiichi Okabe, MD, Goro Sashida, MD, Daigo Akahane, MD, Junko H. Ohyashiki, MD, Kazuma Ohyashiki, MD

Blood (2005) 106 (11): 2860.

https://doi.org/10.1182/blood.V106.11.2860.2860

Published: 2005

Journal Articles

Activity of ABT-737, an Inhibitor of BCL-2 Family Proteins, in Imatinib- or Dasatinib-Resistant CML Cells: Involvement of BCL-2 Family Proteins for Drug Resistance.

Tetsuzo Tauchi, MD, Kousuke Nunoda, MD, Tomoiku Takaku, MD, Masahiko Sumi, MD, Daigo Akahane, MD, Goro Sashida, MD, Junko H. Ohyashiki, MD, Kazuma Ohyashiki, MD

Blood (2005) 106 (11): 3364.

https://doi.org/10.1182/blood.V106.11.3364.3364

Published: 2005

NARROW

Clonal Evolution of Therapy-Related Myeloid Neoplasm Analyzed Sequentially By Targeted Deep Sequencing Using Bone Marrow Cells

BCL2L11 ( BIM ) Deletion Polymorphism Is Associated with Molecular Relapse after ABL Tyrosine Kinase Inhibitor Discontinuation in Patients with Chronic Myeloid Leukemia with Complete Molecular Response

Utility of Percutaneous Image-Guided Biopsy to Diagnose Intraabdominal Lymphoma with Coaxial Core Needles,

Combined Effects of Novel Heat Shock Protein 90 Inhibitor NVP-AUY922 and Nilotinib against Mutant Forms of BCR-ABL

Combined Effects of a Pan-Aurora Kinase Inhibitor MK-0457 and Dasatinib Against T315I Mutant Form of BCR-ABL: In Vitro and In Vivo Studies.

Activity of a Novel Aurora Kinase Inhibitor, VE-465, Against T315I Mutant Form of BCR-ABL: In Vitro and In Vivo Studies.

Identification and Functional Significance of Genes Regulated by Structurally Different ABL Kinase Inhibitors.

Activity of ABT-737, an Inhibitor of BCL-2 Family Proteins, in Imatinib- or Dasatinib-Resistant CML Cells: Involvement of BCL-2 Family Proteins for Drug Resistance.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only